An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle

Journal of Virological Methods

Volumn 67, Issue 1, 1997, Pages 23-34

  Van Oirschot, J T ^b   Kaashoek, M J ^a,b   Maris Veldhuis, M A ^b   Weerdmeester, K ^b   Rijsewijk, F A M ^b  

^a INTERVET INTERNATIONAL BV   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Bovine herpesvirus 1; Differentiation; gE nzyme linked immunosorbent assay; Infection; Vaccination

Indexed keywords

THROMBOSPONDIN; VIRUS ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CATTLE DISEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VIRUS DETECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; IMMUNE SERA; MICE; MICE, INBRED BALB C; SENSITIVITY AND SPECIFICITY; VACCINATION; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE HERPESVIRUS 1; BOVINE RHINOTRACHEITIS VIRUS; HERPES; HERPESVIRIDAE; HERPESVIRUS 1;

EID: 0030738444     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00073-6     Document Type: Article

References (17)

1. Geysen, H.M., Meloen, R.H., Barteling, S.J., 1984. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. USA 81, 3998-4002.
2. Jacobs, C.E., Kimman, T.G., 1994. Epitope-specific antibody responses against glycoprotein E of pseudorabies virus. Clin. Diagn. Lab. Immunol. 1, 500-505.
3. Kaashoek, M.J., Moerman, A., Madic, J., Rijsewijk, F.A.M., Quak, J., Gielkens, A.L.J., Van Oirschot, J.T., 1994. A conventionally-attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12, 439-444.
4. Kaashoek, M.J., Moerman, A., Madić, J.A., Weerdmeester, K., Maris-Veldhuis, M.A., Rijsewijk, F.A.M., Van Oirschot, J.T., 1995a. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13, 342-346.
5. Kaashoek, M.J., Rijsewijk, F.A.M., Maris-Veldhuis, M.A., Van Oirschot, J.T., 1995b. Non essential glycoproteins gC, gG, gI, and gE are expressed in all of 223 isolates of bovine herpesvirus 1. In: Kaashoek, M.J., Marker Vaccines Against Bovine Herpesvirus 1 Infections. Ph.D. Thesis, Utrecht University, The Netherlands.
6. Kaashoek, M.J., Rijsewijk, F.A.M., Ruuls, R.C., Thiry, E., Keil, G.M., Pastoret, P.P., Van Oirschot, J.T., 1995c. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI or gE gene. In: Kaashoek, M.J., Marker Vaccines Against Bovine Herpesvirus 1 Infections. Ph.D. Thesis, Utrecht University, The Netherlands.
7. Kaashoek, M.J., Rijsewijk, F.A.M., Van Oirschot, J.T., 1996. Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Vet. Microbiol. 53, 103-110.
8. Kaashoek, M.J., Van Oirschot, J.T., 1996. Early immunity induced by a live gE-negative bovine herpesvirus 1 vaccine. Vet. Microbiol. 53, 191-197.
9. Kit, S., 1988. Genetically engineered pseudorabies and infectious bovine rhinotracheitis virus vaccines. In: Technological Advances in Vaccine Development. Alan R. Liss, New York, pp. 183-195.
10. Kramps, J.A., Magdalena, J., Quak, J., Weerdmeester, K., Kaashoek, M.J., Maris-Veldhuis, M.A., Rijsewijk, F.A.M., Keil, G., Van Oirschot, J.T., 1994. A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. J. Clin. Microbiol. 32, 2175-2181.
11. Kramps, J.A., Perrin, B., Edwards, S., Van Oirschot, J.T., 1996. A European inter-laboratory trial to evaluate the reliability of serological diagnosis of bovine herpesvirus 1 infections. Vet. Microbiol. 53, 153-161.
12. Perrin, B., Calvo, T., Cordioli, P., Coudert, M., Edwards, S., Eloit, M., Guérin, B., Kramps, J.A., Lenihan, P., Paschaleri, E., Perrin, M., Schon, J., Van Oirschot, J.T., Vanopdenbosch, E., Wellemans, G., Wizigmann, G., Thibier, M., 1994. Selection of European Union standard reference sera for use in the serological diagnosis of infectious bovine rhinotracheitis. Rev. Sci. Tech. Off. Int. Epiz. 13, 947-960.
13. Rijsewijk, F.A.M., Kaashoek, M.J., Madic, J., Paal, H., Ruuls, R., Gielkens, A.L.J., Van Oirschot, J.T., 1993. Characterization of a DNA rearrangement found in the unique short region of the Za strain of bovine herpesvirus type 1 and the vaccine properties of this strain. In: Proc. 18th Int. Herpesvirus Workshop, Pittsburgh, PA, USA, July 25-30, p. C-67.
14. Van Drunen Littel-Van Den Hurk, S., Van Donkersgoed, J., Kowalski, J., Van Den Hurk, J.V., Harland, R., Babiuk, L.A., Zamb, T.J., 1994. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12, 1295-1302.
15. Van Engelenburg, F.A.C., Kaashoek, M.J., Rijsewijk, F.A.M., Van den Burg, L., Moerman, A., Gielkens, A.L.J., Van Oirschot, J.T., 1994. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J. Gen. Virol. 75, 2311-2318.
16. Van Oirschot, J.T., Houwers, D.J., Rziha, H.J., Moonen, P.J.L.M., 1988. Development of an ELISA to detect antibodies to glycoprotein I of Aujeszky's disease virus: a method for the serological distinction between infected and vaccinated pigs. J. Virol. Methods 22, 191-206.
17. Van Oirschot, J.T., Gielkens, A.L.J., Moormann, R.J.M., Berns, A.J.M., 1990. Marker vaccines, virus protein-specific assays and the control of Aujeszky's disease. Vet. Microbiol. 23, 85-101.